• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    长

    长岛犹太医疗中心

    Long Island Jewish Medical Center,Northwell Health
    EST. 1949
    3,934论文总数
    12万引用总数

    Long Island Jewish Medical Center (LIJMC or LIJ) is a clinical and academic hospital within the Northwell Health system. It is a 583-bed, non-profit tertiary care teaching hospital serving the greater New York metropolitan area. The 48-acre (19 ha) campus is 15 miles (24 km) east of Manhattan, on the border of Queens and Nassau Counties, in Glen Oaks, Queens and Lake Success, New York, respectively.LIJMC has three components: Long Island Jewish Hospital, Steven & Alexandra Cohen Children's Medical Center of New York, and The Zucker Hillside Hospital. Long Island Jewish Hospital is a 452-bed tertiary adult care hospital with advanced diagnostic and treatment technology, and modern facilities for medical, surgical, dental and obstetrical care. As a primary teaching hospital for the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (along with North Shore University Hospital) and the Hofstra Northwell School of Nursing and Physician Assistant Studies Island Campus for the Albert Einstein College of Medicine, LIJMC's graduate medical education program is one of the largest in New York State, and programs are in divisions headed by full-time faculty.LIJ's full-time staff includes more than 500 physicians, who supervise care in all major specialties and participate in the medical center's teaching and research programs.The medical center is located on the southeast side of North Shore Towers.The center was founded in 1954 by a group of nine philanthropists, including Jacob H. Horwitz.

    论文量&引用量时间轴

    机构学者

    论文(3935)

    年份
    起
    –
    止
    排序
    1Lifestyle Management Approaches for Obesity
    Matthew J Landry, Zohaib Bagha

    BACKGROUND Lifestyle modification remains the cornerstone of obesity management, serving as an essential component of all treatment plans, even in an era of effective pharmacotherapy. SOURCES OF MATERIAL This review examines the key elements of lifestyle interventions, their mechanisms of action, implementation strategies, and challenges in clinical practice. It additionally discusses the evolving role of lifestyle modification when integrated alongside new pharmaceutical advances, particularly glucagon-like peptide-1 receptor agonists, and how these combined approaches may optimize outcomes in obesity treatment. ABSTRACT OF FINDINGS Effective implementation of lifestyle modification requires a multidisciplinary approach, incorporating exercise counseling, medical nutrition therapy, and behavioral change strategies to address the complex nature of obesity. Nutritional approaches, including various evidence-based dietary patterns, function by creating energy deficits and altering metabolic pathways that influence weight regulation. Physical activity complements dietary interventions by increasing energy expenditure, improving body composition, and enhancing metabolic health. Studies have demonstrated benefits of physical activity for both weight loss and maintenance. Behavioral change techniques are critical for developing sustainable habits, overcoming psychological barriers, and facilitating long-term adherence to lifestyle modifications. CONCLUSION Despite evidence supporting lifestyle modification, challenges limit its use within obesity care, including poor long-term adherence, limited access to specialized facilities and professionals, and inadequate reimbursement for these clinical services.

    2026Journal of clinical lipidology(2026)引用:2
    引用
    AI阅读
    加入学术空间
    2Polygenic Risk Scores and HLA Class II Variants Are Biomarkers of Corticosteroid Response in Childhood Nephrotic Syndrome
    Tiffany Tu, Alejandro Ochoa,Amika Sood, Ashley Dabrik, Megan Chryst-Stangl,Brandon Lane, Guanghong Wu, Frank Donovan,Ursula Harper,Settara Chandrasekharappa, Christopher Esezobor,Adaobi Solarin,

    INTRODUCTION:Nephrotic syndrome (NS), a common glomerular disease in children, is classified based on response to corticosteroid therapy as either steroid-sensitive nephrotic syndrome (SSNS), or steroid-resistant nephrotic syndrome (SRNS). However, there are no current reliable predictors of therapy response at initial clinical presentation. METHODS:To evaluate predictors, we conducted genome-wide association studies, developed polygenic risk scores (PRS) for therapy response and analyzed classical HLA alleles in 1,997 children (994 discovery and 1,003 replication/validation cohorts) previously unstudied children with NS and 3,558 ancestry-matched control individuals. RESULTS:A significant association with HLA loci defined by variants in HLA-DQB1, HLA-DRB1, and HLA-DQA1 were found for SSNS (but not SRNS), along with a second immune-related SSNS locus: CLEC16A. A PRS that discriminates between SSNS and SRNS was validated in two independent cohorts. The HLA haplotype HLA- DRB1∗07:01∼DQA1∗02:01∼DQB1∗02:02 was associated with about four times the risk of developing SSNS. A model incorporating HLA haplotype, PRS score, and age at disease onset was the best predictor of steroid responsiveness with an area under the curve of 0.68-0.70 and an overall classification accuracy of SSNS versus SRNS of 67-71%. CONCLUSIONS:Our findings confirm that SSNS, unlike SRNS, is an immune-mediated HLA-associated disorder. The PRS for therapy response and HLA haplotype can serve as biomarkers, provide a foundation for more accurate diagnoses and tailored individualized treatment.

    2026Kidney international(2026)引用:1
    引用
    AI阅读
    加入学术空间
    3Mentorship Strategies and Illustrative Cases at Every Career Stage
    Adrianne N Haggins, Ryan Walsh, Arthur T Broadstock, Katrina A Gipson, Marianne T Haughey, Pamela Dyne, Maria Moreira, Robert M Rodriguez, Elizabeth E Leenellett,Richelle J Cooper

    Background:Introspection and guidance shape an individual's academic path. Mentorship plays an essential role in intrapersonal development as well as organizational growth. Methods:We present a literature synthesis and case scenarios based on a didactic sponsored by the Academy for Diversity and Inclusion in Emergency Medicine (ADIEM), the Association of Academic Chairs of Emergency Medicine (AACEM), and the SAEM Faculty Development Committee delivered at the Society for Academic Emergency Medicine (SAEM) 2025 Annual Meeting. Results:Mentors' guidance, coaching, and sponsorship are essential at all career stages. Successful mentorship is grounded in the mentee's goals. Mentee self-reflection and communication are key to defining career goals and strategies for success at all career stages, whether in education, research, administrative, or operations. Mentorship can help early-career faculty translate areas of interest into scholarship and advancement and can help mid-career faculty with transitions to leadership positions, as well as mitigate career burnout and enhance satisfaction. Among late-career faculty, mentorship can facilitate a shift toward legacy building, opportunities for growth, and new skill development. Mentors are key allies to help faculty pivot at any stage to ensure goals align with personal satisfaction. Conclusions:Impactful mentorship requires communication, self-discovery, and adaptability. Mutual respect and active engagement with a trusted mentor build the bridge to achieve a career vision and advance the specialty.

    2026AEM education and training(2026)引用:1
    引用
    AI阅读
    加入学术空间
    4P-1000. Evaluating the Efficacy of Oral Vancomycin Primary Prophylaxis to Prevent Clostridioides Difficile Infections in Heart Transplant Recipients
    Adam Grunseich, Reshma George, Patricia Saunders-Hao, Hind El Soufi, Vidal Luchana,Esther Benamu, Rubab Sohail,Pranisha Gautam-Goyal, Sumeet Jain

    Clostridioides difficile is a common cause of hospital-acquired diarrheal infections and immunocompromised patients, including heart transplant patients, are vulnerable to severe Clostridioides difficile infections (CDI). Primary prophylaxis of CDI with oral vancomycin can be utilized in these patients but data regarding efficacy is limited. This was an IRB-approved retrospective observational chart review conducted at North Shore University Hospital evaluating the efficacy of oral vancomycin for primary prophylaxis of CDI in heart transplant recipients admitted between January 2018 and December 2023. The study compared patients who received oral vancomycin prophylaxis (OVP) for CDI with those who did not, based on a protocol change in January 2022. Patients with a history of CDI were excluded. The primary objective was to compare the development of CDI within one-year post-transplant between patients who received OVP and those who did not. The secondary objective was the incidence of vancomycin-resistant Enterococcus infections within one-year post-transplant. Statistical analysis involved Fisher’s exact test for categorical data and Wilcoxon rank-sum test for continuous data. The study included 122 patients. Of these, 44 (36%) did not receive OVP, while 78 (64%) did. For the primary outcome, 2 patients developed CDI within one-year post-transplant, both of whom had not received prophylaxis, but this difference was not statistically significant. These patients developed CDI within 24 days and 39 days respectively. For the secondary outcome, 8 patients developed VRE within one-year post-transplant of which 63% (n=5) received prophylaxis. There was no significant difference in VRE development between those who did and did not receive OVP (6.4% vs. 6.8%, respectively). This study did not show a benefit for OVP in the prevention of CDI in heart transplant recipients without a history of CDI. However, these results have limitations, primarily due to the low incidence of CDI and the small sample size. Further research is needed to assess the efficacy of oral vancomycin primary prophylaxis in heart and other solid organ transplant recipients. All Authors: No reported disclosures

    2026Open Forum Infectious Diseases(2026)
    引用
    AI阅读
    加入学术空间
    5Comparative Diagnostic Utility of SPECT-CT Versus MRI and CT in Chronic Low Back Pain
    Joshua Zhang,John Fallon,Jonathan Elysee, Kaitlyn Lee, Grace Heiting,Chad Simon,Eric Mai,Junho Song, Sean Hilgendorf, Gabriella Chin,Stephen Scharf,David Essig,

    Chronic low back pain (CLBP) frequently arises from degenerative changes that MRI and CT localize imperfectly. This study evaluated the association between single-photon emission computed tomography/computed tomography (SPECT-CT) positivity and structural degenerative findings on MRI and CT, and identified structural findings that independently predict SPECT-CT positivity. In a retrospective single-institution cohort, patients ≥ 18 years who underwent MRI and SPECT-CT for back pain > 3 months refractory to physical therapy were analyzed. MRI defined Modic changes and Pfirrmann grade (1–3 vs. 4–5); CT defined vacuum disc and vacuum facet phenomena. SPECT positivity was classified as endplate (EP), facet, or any. Spearman correlations, multivariable logistic regression (backward elimination), and cross-tabulation of structural-metabolic concordance assessed relationships between modalities. Among 122 patients (610 levels), SPECT-EP correlated with Modic changes (r = 0.455), Pfirrmann 4–​5 (r = 0.475), and vacuum disc (r = 0.483) (all p < 0.001); vacuum facet correlated with SPECT-facet (r = 0.400, p < 0.001). Independent predictors of SPECT-EP positivity were Modic changes (OR 6.40, 95

    2026European Spine Journal(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3935 篇论文

    合作机构(100)

    诺思韦尔卫生合作论文 166
    哥伦比亚大学合作论文 106
    费城儿童医院合作论文 84
    北岸大学医院合作论文 70
    密歇根大学合作论文 66
    纽约大学合作论文 61
    华盛顿大学合作论文 59
    杜克大学合作论文 54
    辛辛那提儿童医院医学中心合作论文 54
    Donald and Barbara Zucker School of Medicine at Hofstra/Northwell合作论文 53

    机构统计